Literature DB >> 16771678

Effects of noradrenaline on neuronal NOS2 expression and viability.

Jose L M Madrigal1, Cinzia Dello Russo, Vitaliy Gavrilyuk, Douglas L Feinstein.   

Abstract

The authors previously showed that conditioned media (CM) from activated microglia increased inducible nitric oxide synthase (NOS2) in cortical neurons. Here they examined the ability of noradrenaline (NA) to reduce neuronal NOS2 or cell death. Primary mouse cortical neurons were activated using CM from microglia incubated with lipopolysaccharide (LPS). Neuronal NOS2 was assessed by increases in nitrite accumulation, and increases in NOS2 mRNA levels and fluorescence of the NO-sensitive probe DAF-2 DA. NOS2 induction was associated with an increase in neuronal LDH release. When NA was added during microglial activation, neuronal NOS2 was significantly reduced (by approximately 70%); in contrast if NA was added to the neurons along with CM, there was less reduction (about 35% decrease) in NOS2 expression. NA added to either microglia or to neurons reduced neuronal LDH release comparably. Pretreatment of CM with blocking antibody to TNFalpha, alone or with IL1-receptor antagonist, partially reduced neuronal cell death and NOS2. Incubation of neurons with NA increased IkBalpha, which could reduce NOS2. These results demonstrate that NA modulates neuronal NOS2 expression and damage, and that these effects are primarily due to inhibition of microglia released factors. Perturbations of NA could exacerbate neuronal damage by allowing for increased inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771678     DOI: 10.1089/ars.2006.8.885

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  15 in total

1.  Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Paul E Polak; Sergey Kalinin; Douglas L Feinstein
Journal:  Brain       Date:  2011-02-04       Impact factor: 13.501

2.  The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease.

Authors:  Sergey Kalinin; Paul E Polak; Shao Xia Lin; Amul J Sakharkar; Subhash C Pandey; Douglas L Feinstein
Journal:  Neurobiol Aging       Date:  2011-06-25       Impact factor: 4.673

3.  Increasing CNS noradrenaline reduces EAE severity.

Authors:  Maria Vittoria Simonini; Paul E Polak; Anthony Sharp; Susan McGuire; Elena Galea; Douglas L Feinstein
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-04       Impact factor: 4.147

4.  Nitric Oxide Synthesis is Modulated by 1,25-Dihydroxyvitamin D3 and Interferon-gamma in Human Macrophages after Mycobacterial Infection.

Authors:  Ji-Sook Lee; Chul-Su Yang; Dong-Min Shin; Jae-Min Yuk; Ji-Woong Son; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

5.  CCL2 Induces the Production of β2 Adrenergic Receptors and Modifies Astrocytic Responses to Noradrenaline.

Authors:  Irene L Gutiérrez; Marta González-Prieto; Borja García-Bueno; Javier R Caso; Douglas L Feinstein; José L M Madrigal
Journal:  Mol Neurobiol       Date:  2018-02-24       Impact factor: 5.590

6.  CCL2/MCP-1 modulation of microglial activation and proliferation.

Authors:  Ara E Hinojosa; Borja Garcia-Bueno; Juan C Leza; Jose L M Madrigal
Journal:  J Neuroinflammation       Date:  2011-07-05       Impact factor: 8.322

7.  Dual effects of noradrenaline on astroglial production of chemokines and pro-inflammatory mediators.

Authors:  Ara E Hinojosa; Javier R Caso; Borja García-Bueno; Juan C Leza; José L M Madrigal
Journal:  J Neuroinflammation       Date:  2013-07-09       Impact factor: 8.322

Review 8.  Noradrenergic Modulation of Cognition in Health and Disease.

Authors:  Olga Borodovitsyna; Matthew Flamini; Daniel Chandler
Journal:  Neural Plast       Date:  2017-05-03       Impact factor: 3.599

9.  Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia.

Authors:  Johannes C M Schlachetzki; Bernd L Fiebich; Elisabeth Haake; Antonio C P de Oliveira; Eduardo Candelario-Jalil; Michael T Heneka; Michael Hüll
Journal:  J Neuroinflammation       Date:  2010-01-11       Impact factor: 8.322

10.  Endogenous IL-6 of mesenchymal stem cell improves behavioral outcome of hypoxic-ischemic brain damage neonatal rats by supressing apoptosis in astrocyte.

Authors:  Yan Gu; Mulan He; Xiaoqin Zhou; Jinngjing Liu; Nali Hou; Tan Bin; Yun Zhang; Tingyu Li; Jie Chen
Journal:  Sci Rep       Date:  2016-01-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.